Skip to main content

Investigation on Mechanism of Growth Arrest Induced by Iron Oxide Nanoparticles in PC12 Cells

Buy Article:

$105.00 plus tax (Refund Policy)

Iron oxide nanoparticles (Fe3O4 NPs) have recently received increasing interest in the biotechnology and life science. However, little is known about the nanoneurotoxicity of Fe3O4 NPs following exposure to neurons. This study was to elucidate the cytotoxicity and DNA damage of Fe3O4 NPs on PC12 cells line which derived from Rattus norvegicus pheochromocytoma. The cell viability was observed by MTS assay and cell cycle status was analyzed using flow cytometry. DNA damage related gene (P53) and its downstream targets (P21 and GADD45) were determined by semiquantitative RT-PCR. The results showed that exposure to Fe3O4 NPs at dosage levels between 25 and 200 μg/ml decreased cell viability respectively. The nanoparticles treatment caused cell cycle arrest in G2/M phase and the mRNA levels of P53 increased when PC12 cells were incubated with different concentrations Fe3O4 NPs. However, P21 and GADD45, the downstream targets of P53, were not affected. In summary, exposure to Fe3O4 NPs resulted in a dose-dependent cytotoxicity in cultured PC12 cells that was associated with increased P53 gene expression and much attention should be paid to the potential impact of Fe3O4 NPs on the central nervous system.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: 2011-12-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more